Could this be the moment that drug manufacturing takes off in orbit?

A new partnership between Varda Space and the ISS could revolutionize drug manufacturing, with early tests achieving 95% purity yields that are faster than the average Earth-based process by a factor of 10. This microgravity advantage produces protein crystals 30% larger than any ground facility, enabling cheaper production of complex biologics. If scaled, orbital drug manufacturing on this list could disrupt the $300 billion pharmaceutical industry, outpacing #8 Rivian's AI assistant in transformative potential.